EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic Outcomes of Enterococcal Urinary Tract Infections: A Retrospective Analysis from Saudi Arabia and Oman

Abrar K Thabit iD, Juhaina S Al-Maqbali iD, Khaled F Alharthi, Salem M Baotab, Abdullah M Bankhar, Rayyan M Wali, Mohammed O Alzahrani, Asiya K Alharthi, Taqwa M Alhamsaidi, Ibrahim Al Busaidi, Ahmad J Mahrous iD, Jimmy Jose

Pathogens · 2026

DOI: 10.3390/pathogens15030250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Abrar K Thabit und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Gram-Positive Bacterial Infections, Enterococcus faecalis. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAU Endowment (WAQF) at King Abdulaziz University, Jeddah, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enterococcus species are involved in urinary tract infections (UTIs), and they are known to be intrinsically resistant to certain antibiotics. We aimed to investigate the clinical characteristics and treatment outcomes of enterococcal UTIs in three hospitals in Saudi Arabia and Oman.

Methods

A retrospective cohort study was conducted on adults with clinically and microbiologically confirmed enterococcal UTI based on urinary symptoms and a urine culture of ≥100,000 CFU/mL, who received an antibiotic active against the pathogen. The primary endpoint was clinical cure. Secondary endpoints included microbiological cure, length of stay (LOS), in-hospital mortality, and recurrence.

Results

E. faecalis and E. faecium were isolated from 188 (67.1%) and 92 (32.9%), respectively, of 280 included patients. Ampicillin/amoxicillin (25%) and vancomycin (22.1%) were the most-used antibiotics. Compared with E. faecium, E. faecalis was associated with higher clinical cure rates (75% vs. 57.6%; p = 0.003), lower in-hospital mortality (15.7% vs. 38.5%; p < 0.0001), and shorter LOS (12.5 vs. 25 days; p < 0.0001). No difference in recurrence was observed. Ciprofloxacin was associated with high odds of clinical cure (OR, 4.28; 95% CI, 1.18–15.56). Conversely, the recent cancer chemotherapy and growth of Enterococcus at another site were associated with lower odds of clinical cure. Urinary catheter removal was associated with lower recurrence odds (OR, 0.48; 95% CI, 0.24–0.98).

Conclusions

This study highlights the clinical challenges posed by enterococcal UTIs, particularly by E. faecium. Ciprofloxacin remains an effective option, particularly against E. faecalis. Patients with advanced age, critical illness, complicated infections, and liver disease, as well as patients on hemodialysis, require close monitoring to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsAnti-Bacterial AgentsGram-Positive Bacterial InfectionsEnterococcus faecalisEnterococcus faeciumEnterococcusHumansRetrospective StudiesSaudi ArabiaFemaleMaleOmanTreatment OutcomeMiddle AgedAdultAged

Stichwörter der Autor:innen

EnterococciEnterococcus faecalisEnterococcus faeciumantibioticsoutcomesurinary tract infection

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
  • Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Science, Sultan Qaboos University, Muscat 123, Oman.
  • Department of Pharmacy, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman.
  • Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
  • School of Pharmacy, University of Nizwa, Nizwa 616, Oman.
  • Department of Medicine, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman.

ORCID-Profile: Abrar K Thabit, Juhaina S Al-Maqbali, Ahmad J Mahrous

Förderung

  • KAU Endowment (WAQF) at King Abdulaziz University, Jeddah, Saudi Arabia

Zitieren

APA

Thabit, A. K., Al-Maqbali, J. S., Alharthi, K. F., Baotab, S. M., Bankhar, A. M., Wali, R. M., Alzahrani, M. O., Alharthi, A. K., Alhamsaidi, T. M., Al Busaidi, I., Mahrous, A. J., & Jose, J. (2026). Antibiotic Outcomes of Enterococcal Urinary Tract Infections: A Retrospective Analysis from Saudi Arabia and Oman. Pathogens. https://doi.org/10.3390/pathogens15030250

Vancouver

Thabit AK, Al-Maqbali JS, Alharthi KF, Baotab SM, Bankhar AM, Wali RM, et al. Antibiotic Outcomes of Enterococcal Urinary Tract Infections: A Retrospective Analysis from Saudi Arabia and Oman. Pathogens. 2026. doi:10.3390/pathogens15030250

BibTeX
@article{Thabit2026,
  author = {Thabit, Abrar K and Al-Maqbali, Juhaina S and Alharthi, Khaled F and Baotab, Salem M and Bankhar, Abdullah M and Wali, Rayyan M and Alzahrani, Mohammed O and Alharthi, Asiya K and Alhamsaidi, Taqwa M and Al Busaidi, Ibrahim and Mahrous, Ahmad J and Jose, Jimmy},
  title = {Antibiotic Outcomes of Enterococcal Urinary Tract Infections: A Retrospective Analysis from Saudi Arabia and Oman},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15030250}
}
Kostenlos starten →